Amin công khai
[search 0]
Thêm

Download the App!

show episodes
 
This is a podcast made by scientists for scientists, to help you save time so you can conduct better research. For a given month, we sort the abstracts of the latest primary research articles on Alzheimer's disease into separate categories. We then summarize them for you to enjoy on the bus, on your jog, or in the lab. We hope you find our podcast useful and accessible. For questions or feedback, contact us at amindrpodcast@gmail.com .
 
اینجا در مورد سرگرمی صحبت میکنم. در مورد کتاب، فیلم، سریال، بازی و چیزهایی که در مورد سرگرمی. همینطور میتونید مطالب آموزشی در مورد مسائل عمومی و تخصصی هم پیدا کنید میتونید ویدئوها رو در کانال یوتیوب من ببینید
 
WELCOME TO SIMURGH -CONFERENCE OF BIRDS. THIS PODCAST IS A PLATFORM FOR COMMUNITY ENGAGEMENT, PEACEBUILDING, EDUCATION, COACHING, MENTORING AND TRAINING. THE HOST AMIN BEG, IS A DEVELOPMENT PRACTITIONER, CONFLICT ANALYST, SOCIAL AND CLIMATE ACTIVIST AND IMPACT INVESTMENT FACILITATOR. THE TALKS, INTERVIEWS, STORIES, RELATE TO COMMUNITY DEVELOPMENT, CLIMATE CHANGE, PARTICIPATORY GOVERNANCE, YOUTH AND WOMEN AFFAIRS, ENTREPRENEURSHIP AND IMPACT INVESTING.
 
سلام من امین هستم و اینجا زبان انگلیسی درس میدم . پادکست ها رو گوش کن و اگه خوشت اومد به دوستاتم معرفی کن ____________________ آدرس کانال تلگرام: https://t.me/LearningWithAmin آدرس صفحه اینستاگرام : https://instagram.com/learningwithamin?igshid=i70p75yje15x آدرس کانال یوتیوب: https://www.youtube.com/channel/UCA5gWQAUNlEQbj65T6-S6gw حمایت مالی از پادکست: https://idpay.ir/aminpodcaster (Iran) https://hamibash.com/aminpodcaster (Iran & Foreign)
 
In 2001, Marvel's X-Men comics had just gone through ten years of stagnation. In sharp contrast to the monumental changes Chris Claremont routinely introduced to the characters, the X-Men had become a safe comic afraid to take risks. In an attempt to finally shake things up, Marvel tapped Grant Morrison, writer of JLA and The Invisibles, to reinvent the X-Men for a new generation. And for the first time since Claremont's initial run, Morrison introduced sweeping and controversial changes, th ...
 
Loading …
show series
 
In Part 2 of Cognitive and Behavioural Changes, Naila covers 8 papers on neuropsychiatric, social and cognitive symptoms linked to Alzheimer's disease, and their implications for diagnosis and disease management. You'll learn about the links between AD and depression, the importance of social networks, and machine learning methods for identifying i…
 
In this episode, Naila will guide you through 14 papers on potential neuroprotective factors to mitigate the risk of Alzheimer's disease, non-pharmacological interventions that could directly target Alzheimer's pathology, and strategies for symptom management. You'll hear about the role of embodiment in memory, light therapy technologies, the role …
 
This is an episode all about targeting synaptic and neuronal heath in Alzheimer's disease. Anusha will cover in silico, in vitro, and in vivo studies of candidate compounds that target neuroprotection and neurogenesis. Be sure to check out this paper to stay up to day on the latest preclinical therapeutics being tested. Sections in this episode: In…
 
In this episode exploring the effect of allelic variation of APOE, we review abstracts from large human GWAS studies all the way down to new mouse models expressing the human ApoE proteins. There are some particularly interesting abstracts on protection from cognitive decline despite having a risk allele for Alzheimer's disease. These are great stu…
 
Part 1 of our cognitive and behavioural changes category will focus on papers that explore behavioural and sensory processing deficits in AD. Topics range from motor impairments to visual and olfactory processing in both human patients and mouse models of AD. If you're curious about how AD patients process the facial expression of pain, then this i…
 
Elyn is back to discuss the latest research on vascular contributions to Alzheimer disease! Tune in to hear about proteomic changes with amyloid deposition in the vasculature, new therapeutic avenues, and a more detailed account of the perivascular space. If you're interested in factors beyond amyloid and tau in the Alzheimer disease pathology, thi…
 
We are kicking off our July 2022 series of AMiNDR with this episode and are so glad you are tuning in. If you’re interested in changes to neuronal function in AD, we’ll be covering the entire spectrum in this episode. Starting big with network changes, we scale all the way down to molecular changes that may underlie AD pathology, so if that’s what …
 
On this episode we discuss patient / doctor relations. We focus on how communication is key between doctor and patient and the patient must be proactive when it comes to their health . One example is how Amin who is living with a form of cancer that is only treatable. In his case the doctors successfully got him into remission but he still has many…
 
Today's episode includes 15 papers on non-pharmacological treatments and complementary therapies for AD. Naila will take you through research published in June 2022 on an array of topics including olfactory training, beer, choir participation, light therapy, and transcranial magnetic stimulation. You'll be treated to research on both the human and …
 
We promised you we would be back with more on clinical assessment for Alzheimer’s disease, and here we are to deliver. Stick around to hear about papers published in June 2022 on validating variations of the Montreal Cognitive Assessment, tracking Activities of Daily living, and digital tools for assessing cognition. Our harvest yielded 7 abstracts…
 
Approximately, one in every five people you know, has a copy of the largest genetic risk allele for late-onset Alzheimer's disease called apolipoprotein E4 (APOE). In this episode, Cassi discusses papers from June 2022 about APOE and covers human subjects research, pathology related to E4 risk, and mechanisms. Sections in this episode: Human Subjec…
 
In this episode, Joseph covers papers published in June 2022 on GWAS studies, transcriptomics, genetic and genomic studies and the like on Alzheimer’s disease. Stay tuned! Sections in this episode: Genetic & Disease Overlaps (2:15) RNA & Transcriptomics (5:10) Genetic Testing (10:25) GWAS Studies (15:24) Specific Genes (21:04) Extra (28:55) -------…
 
Anusha brings you 12 papers today on the development of treatments that target neuroprotection in Alzheimer's disease. This includes a range of research models, from in silico and drug discovery studies, to rodent models of AD. Enjoy! Sections in this episode: In Silico and Drug Discovery Studies (2:27) Testing Phytochemicals in AD Rodent Models (7…
 
This episode contains a whole range of topics in cognitive and behavioural changes in AD! Tune in as Judy covers a variety of papers published in June 2022, spanning from from sensory processing in mouse models to antidepressants in human patients. There's bound to be something that piques your interest! Sections in this episode: Studies Using Mous…
 
You are here, with us, right now, about to get the updates you eagerly wait for every month in Alzheimer’s disease research. A whole episode dedicated to assessing neurocognitive domains for screening and diagnostics. Learning and memory? Executive function? Perceptual and motor skills? You got it! 7 abstracts published in June 2022, nicely package…
 
Ever thought there was more to Alzheimer disease than the plaques and tangles? You've come to the right place. Join Elyn for a guide through the latest research on vascular contributions to Alzheimer disease. June 2022 brought lots of new insight into how vascular hallmarks interact with the classic AD hallmarks to influence cognition, emphasis on …
 
We are kicking off our June 2022 series of episodes with this short and sweet episode. Anusha takes a look at papers published on the subject of changes to synaptic transmission and neuronal excitability in Alzheimer’s disease. If you're interested in bridging the gap between changes to neuronal function and behavioural consequences, this episode i…
 
On this episode of Podcasting with Amin Bonita and Loren are joined by brother and sister duo Shannon and Marlin Bonds also known as Mz.007 and Hookman. After both were in the industry for quite some they hadn't had the opportunity to work to get until years ago when they came up with the hit song and video for Mz. 007 titled " Important". Despite …
 
Elyn is back with a short and sweet episode on the latest research on vascular contributions to Alzheimer disease! Tune in for a quick recap of May 2022 research, and a disease perspective a bit more lively than the classic amyloid cascade hypothesis! Clinical Studies (3:53) Preclinical Studies/Methology (12:41) ------------------------------------…
 
Anusha is excited to guide you through 12 papers published in May of 2022 that all test different treatment options for Alzheimer’s disease, preclinically. She will cover topics like discovery and development of agents that confer neuronal and synaptic protection or target neuronal function directly. This episode is sure to leave you feeling hopefu…
 
In this exciting episode, Judy goes over papers published in May 2022 on the latest research involving cognitive, behavioural and clinical changes in AD. Subjects include sensory processing, mouse models, sleep, and many more! Sensory Processing (1:45) Mouse Models (5:44) Clinical Treatments (8:34) Sleep (12:59) Other (17:29) ----------------------…
 
Necessity definitely is the mother of invention and our guest today live that phrase as they have created businesses out of those necessities. We have Ms. Patricia Blanks a former educator and administrator who is all about promoting positive self esteem, so she wrote the book titled " It's time for Kindergarten PJ and Parker. A book that promotes …
 
On this Episode we put the spotlight on racial and ethnic differences in children identified with Autism Spectrum Disorder (ASD). We speak Anitra Cole who has a son with autism, Anitra is working hard to get legislation passed to improve funding underserved communities. Adding to the conversation we have Dr. Michael Quinn who is the Chief Operating…
 
In this episode, Joseph is back to go over papers published in May 2022 on GWASs, genetics or any other genetics-focused work. Topics include GWAS's, tool development, gene discovery, and social performance-based genetic studies! GWAS and Polygenic Risk Scores (2:20) Cognitive & Social Genetic Studies (8:42) Tool development (11:46) Gene Discovery …
 
Welcome welcome! This episode was made for you if you are interested in geriatrics, neurology, or cognitive testing in general, as we will go through the latest publication on clinical assessment of cognitive decline. That’s right, 9 papers published in May 2022 on testing neurocognitive domains for the screening or diagnosis of mild cognitive impa…
 
AMiNDR is back and excited to bring you more literature on Alzheimer’s Disease. In this episode, we’ve got papers published in May of 2022 on the subject of changes to synaptic transmission and neuronal excitability. Anusha covers subjects like calcium homeostasis, synaptic function, and how to translate findings to humans and human models, so join…
 
In the final episode of the March 2022 series, Naila takes you through 18 papers on non-pharmacological strategies for preventing or treating Alzheimer's disease. You'll hear the latest from animal studies on exercise, learn about the potential benefits of brown rice, pet ownership and yoga, and be guided through a number of techniques that are bei…
 
On this episode we discuss the the call. Yes the spiritual calling that brings many to the ministry to serve the Lord and people on a higher level. We jump knee deep into the conversation with two ordained ministers cut from two very different sides of the holy cloth. On one side we have Willie Seals III minister for Jesus sharing his trials and tr…
 
Welcome back for the second of a 2-part episode on the clinical assessment of Alzheimer’s disease, based on abstracts published in March 2022! You will hear about the evaluation of traditional and digital tests for their potential to help us detect AD and distinguish it from MCI. Also on the menu, a few papers on markers of cognitive decline that m…
 
The final episode in the re-read of Grant Morrison's New X-Men run! This finale features a callback to two classic X-Men stories—The Dark Phoenix Saga and Days of Future Past. 150 years in the future, the X-Men led by Wolverine and Cassandra Nova Xavier are locked in a battle with the Beast over the fate of the newly resurrected Phoenix! We discuss…
 
This is our monthly update on clinical assessment of Alzheimer’s disease, based on abstracts published in March 2022! This is the first of a 2-part series on the matter, where we bring together ways to assess cognitive function by looking at one neurocognitive domain, such as learning and memory, language, perceptual-motor skills, and even by looki…
 
Another 12 papers published in March of 2022 awaits you. This episode is all about treatments that target neuroprotection to treat AD. The papers model it by inducing cytotoxicity in the brain, either with molecules like amyloid beta or genetic mutations. Anusha is excited to guide you through promising treatment options, are you excited too? Secti…
 
We now come to possibly the most controversial arc in Morrison's run, where Xorn was revealed to be Magneto in disguise the whole time. We discuss the fan reaction to these issues back in the day, Marvel's rapid and sloppy attempts to undo the revelations, our own theories for what the arc was really about, and so much more! Issues Covered: New X-M…
 
Ease in to our March 2022 series with 8 papers published on the subject of synaptic transmission in Alzheimer's Disease. Anusha will highlight changes to connectivity and ones caused by APP and Tau proteins so check out this episode to bridge the communication gap in your brain too! Sections in this episode: Synaptic Connectivity Changes (1.44) APP…
 
In the Black community, one is often told to “be strong,” or “there’s nothing wrong with you,” in times of stress, trauma, drug addiction or poor state of mental health. While also facing racism, discrimination, and lack of access to mental health care, statistics show there’s a growing need for mental health to be properly addressed among those in…
 
All three of us are back together to discuss the "guy's night out" story-arc. Cyclops has left the X-Men after Jean learned of his psychic affair. Wolverine beats Cyclops in a drinking contest, then drags him along on a raid on Weapon Plus and The World with Fantomex. We get an action-packed arc that plays to Chris Bachalo's artistic sensibilities …
 
Loading …

Hướng dẫn sử dụng nhanh

Google login Twitter login Classic login